Connect with us:
With the advances in medical science, clinical research has evolved into an innovative tool that no pharmaceutical company can do without.
Clinical trials are critically important to the drug development process. Before a new drug enters a market, it is mandatory for its innovation to be first validated through clinical trials. Be it for a new drug combination or novel formulations or any new development on existing molecules, clinical trials need to be carried out using protocols that adhere to accepted standards of safety, patient care and data interpretation.
Ipca has a full fledged, in-house clinical research function, set up since 2007, which undertakes all activities involved in clinical trails – right from concept of product till ensuring the study results are published in international peer reviewed journals and application is duly filed to the Drug Controller General of India. The core functions that are performed by Ipca’s clinical research function are: investigator identification and selection, medical writing, clinical operations and filing and defending submissions.
The distinct feature of Ipca’s clinical research function is that we mainly focus on exploring hidden potential of existing, non patented products. The main therapeutic areas we focus on are Cardiovascular, Pain Management, Malaria, Infections, Endocrinology, Gynecology, Psychiatry, Dyslipidemia and Dermatology.
At Ipca, through research, we facilitate the development of new chemical entities, innovative therapies and support research on novel drug delivery systems, keeping the well-being and safety of patients at the core of our every endeavor.
Our path-breaking scientific expertise, quality commitment and benchmark ethical practices enable us to carry out clinical development of new molecular entities and novel therapies better, faster and with a high level of accuracy. We are committed to the safety of patients who take part in our trials, and uphold the highest ethical, scientific, and clinical standards in all of our research initiatives.